Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nigella Sativa Nasal Oil in Chronic Rhinosinusitis
NCT05494164Completed
- Sponsor
- Cairo University
- Start
- Aug 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of nigella sativa in chronic rhinosinusitis (CRS) (2 arms), sponsored by Cairo University. Primary endpoints: Sino-Nasal Outcome Test 22 and Sleep Quality Scale. Started Aug 2022; status: completed.
02
Drugs
nigella sativa
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT05494164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494164.